Methicillin-resistant Staphylococcus aureus clones, Western Australia
Coombs, G.W., Pearson, J.C., O'Brien, F.G., Murray, R.J., Grubb, W.B. and Christiansen, K.J. (2006) Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerging Infectious Diseases, 12 (2). pp. 241-247.
*No subscription required
Community-associated methicillin-resistant Staphylococcus aureus (MRSA) was first reported in Western Australia in the early 1990s from indigenous peoples living in remote areas. Although a statewide policy of screening all hospital patients and staff who have lived outside the state for MRSA has prevented the establishment of multidrug-resistant epidemic MRSA, the policy has not prevented SCCmec type IV and type V MRSA clones from becoming established. Of the 4,099 MRSA isolates analyzed (referred to the Gram-positive Bacteria Typing and Research Unit) from July 2003 to December 2004, 77.5% were community-associated MRSA (CA-MRSA). Using multilocus sequence/staphylococcal chromosome cassette mec typing, 22 CA-MRSA clones were characterized. Of these isolates, 55.5% were resistant to >1 non–β-lactam antimicrobial drug. Five Panton-Valentine leukocidin (PVL)–positive CA-MRSA clones were identified. The emergence of multidrug-resistant CA-MRSA clones and the detection of PVL toxin genes in clones previously reported as PVL negative is a major public health concern.
|Publication Type:||Journal Article|
|Publisher:||National Center for Infectious Diseases|
|Item Control Page|
Downloads per month over past year